Now with real-time glucose readings sent right to your patients’ smartphones◊,¤
Glucose readings are sent directly to patients' smartphones◊,¤ every minute, of every hour, of every day for up to
15 days.
The only sensor-based glucose monitoring system that can fill in data gaps with a quick scan when Bluetooth®1
is unavailable.
Automatically* uploads glucose data to a secure^ cloud-based system accessible to HCPs and caregivers◊,2. With the LibreLinkUp app§, caregivers always have access to their loved ones' glucose data and can set their own real-time glucose alarm notifications.
The LibreLink app makes it easy for patients to share their glucose readings with you and their family members.
Readings from the LibreLink app◊ are automatically7 uploaded to LibreView2 for more informed patient consultations and treatment decisions, while data can be shared with family members using LibreLinkUp.§
Patients can scan their sensor to fill in up to 8 hours of missing data for a complete glucose history.
The FreeStyle Libre 2 system is proven to have significant clinical and real-world benefits for patients with diabetes.
95% of patients have a better
understanding of their glucose
fluctuations3
Proven to decrease HbA1c9,10
and increase Time in Range5,7,10
Reduces time spent in hypoglycaemia
(<3.9 mmol/L) by 38% in T1D11 and 43% in T2D5
compared to self-monitoring
of blood glucose
A small and discreet sensor5, worn on the back of the upper arm that continuously measures the glucose concentration in the body’s interstitial fluid.
Real-time glucose readings from the
Libre 2 Plus sensor are sent
directly to patients’ smartphones.◊,¤
Images are for illustrative purposes only. Not real patients, healthcare professionals, or data.
1. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Abbott is under license.
2. The LibreView website is only compatible with certain operating systems and browsers. Please check www.LibreView.com for additional information.
3. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809.
4. Alva, S. J Diabetes Sci Technol (2020): https://doi.org/10.1177/1932296820958754.
5. Haak, T. Diabetes Therapy (2017): https://doi.org/10.1007/s13300-016-0223-6.
6. Unger, J. Postgrad Med. (2020): https://doi.org/10.1080/00325481.2020.1744393.
7. Lameijer, A Diabetes Res Clin Practice (2023). https://doi.org/10.1016/j.diabres.2023. 110735.
8. Hilliard, M., et al. Diabetes Technology & Therapeutics. (2019): https:/doi.org/10.1089/dia.2019.0142.
9. Yaron, M. et al. Diabetes Care (2019): https://doi.org/10.2337/dc18-0166.
10. Leelarathna, L. et al. Engl J Med. (2022): https://doi.org/10.1056/NEJMoa2205650.
11. Bolinder, J. et al. Lancet (2016): https://doi.org/10.1016/S0140-6736(16)31535-5.
12. NICE guideline NG17 (2015) Last updated: 17 August 2022; available at https://www.nice.org.uk/guidance/ng17. Accessed June 2026.
13. NICE guideline NG28 (2015) Last updated: 18 February 2026; available at https://www.nice.org.uk/guidance/ng28. Accessed June 2026.
◊ The LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of LibreLink may require registration with LibreView.
‡ 60-minute warm-up required when applying the sensor.
₸ Sensor is water-resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
¤ Glucose readings are automatically displayed in the LibreLink app only when your patients’ smartphone and sensor are connected and in range.
* The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.
^ Libreview is ISO27001/27018/27701 certified and HITRUST CSF certified.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkUp.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
ǁ Notifications will only be received when alarms are turned on and the sensor is within 6 metres (20ft) unobstructed of the reading device.
ADC-2641599 v8.0
The "Yes" link below will take you to a website other than Abbott Laboratories. Links to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or any link contained in such websites. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
If you're a healthcare professional located in a different country, please select your country's website from the list of our global sites or contact your local Abbott representative for correct information about the products available in your country.
If you're not a healthcare profressional, click here to go to the FreeStyle Libre consumer website for the UK.
.svg){kind=logo}
